Crit Care. 2023 Oct 19;27(1):400. doi: 10.1186/s13054-023-04690-5.
PMID:37858258
Hydrocortisone plus fludrocortisone for community acquired pneumonia-related septic shock: a subgroup analysis of the APROCCHSS phase 3 randomised trial.
Heming N, Renault A, Kuperminc E, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Leone M, Timsit JF, Misset B, Benali MA, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Bounab R, Maxime V, Moine P, Bellissant E, Annane D; APROCCHSS investigators; CRICS-TRIGGERSEP network.
Re: Septic shock and adequacy of early empiric antibiotics in the emergency department.
Schaeffer EM.
J Urol. 2015 Apr;193(4):1263-4. doi: 10.1016/j.juro.2015.01.025. Epub 2015 Jan 16.
PMID:25890515
Early Screening of Risk for Multidrug-Resistant Organisms in the Emergency Department in Patients With Pneumonia and Early Septic Shock: Single-Center, Retrospective Cohort Study.
Yiang GT, Tzeng IS, Shui HA, Wu MY, Peng MY, Chan CY, Chan ED, Wu YK, Lan CC, Yang MC, Huang KL, Wu CW, Chang CH, Su WL.
Shock. 2021 Feb 1;55(2):198-209. doi: 10.1097/SHK.0000000000001599.
PMID:32694392
Management of septic shock and severe infections in migrants and returning travelers requiring critical care.
Aminoglycosides in Immunocompromised Critically Ill Patients With Bacterial Pneumonia and Septic Shock: A Post-Hoc Analysis of a Prospective Multicenter Multinational Cohort.
Lopez R, Rello J, Taccone FS, Salem OBH, Bauer PR, Séguin A, van de Louw A, Metaxa V, Klouche K, Martin Loeches I, Montini L, Mehta S, Bruneel F, Lisboa T, Viana W, Pickkers P, Russell L, Rusinova K, Kouatchet A, Barbier F, Mokart D, Azoulay E, Darmon M.